Insider filing · MDGL
Rebecca Taub
Pres., R&D, and CMO
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
Rebecca Taub sold $462K of Madrigal Pharmaceuticals (MDGL)
Executed Jan 17 2025, disclosed Jan 17 2025, the same day.
Value, as filed
$462K
1,689 sh × $273.41
Executed
Jan 17 2025
the trade date, as filed
Disclosed
Jan 17 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RTRebecca Taub (Pres., R&D, and CMO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $10.3M of MDGL (18,650 sh across 9 lots, as filed), executed Dec 10 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rebecca Taub in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$212K491 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $319K
647 sh × $492.42
Exec Jan 26
Filed Jan 26 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.1M
2,238 sh × $490.77
Exec Jan 20
Filed Jan 20 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $9.5M
18,171 sh across 23 lots
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $110K
200 sh × $551.24
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $10.3M
18,650 sh across 9 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $16.4M
46,243 sh across 11 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $350K
1,000 sh × $350.01
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET